Medicare Enrolled

Dr. Victor Abraham, MD

Urology Physician · Wilmington, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1099 MEDICAL CENTER DR, Wilmington, NC 28401
9102549995
In practice since 2006 (20 years)
NPI: 1003848540 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abraham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abraham? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abraham

Dr. Victor Abraham is an urology physician in Wilmington, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Abraham performed 180,898 Medicare services across 4,487 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abraham received a total of $5,653 from 39 pharmaceutical and/or device companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abraham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in NC $5,653 industry payments

Medicare Practice Summary

Medicare Utilization ↗
180,898
Medicare services
Top 0% in NC for urology physician
4,487
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9,045 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
171,142 $0 $0
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
2,608 $2 $5
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
2,074 $7 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,929 $84 $167
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
1,276 $10 $22
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
289 $174 $239
Leuprolide acetate (for depot suspension), 7.5 mg 222 $134 $215
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
221 $121 $206
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
191 $70 $155
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
149 $64 $98
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
134 $90 $125
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
80 $60 $102
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
74 $23 $38
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
64 $0 $1
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
58 $116 $170
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
49 $128 $189
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
38 $43 $73
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
36 $19 $52
Injection, garamycin, gentamicin, up to 80 mg 35 $2 $4
Imaging guidance for procedure, 60 minutes or less
Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less.
31 $12 $50
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
29 $158 $260
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
24 $239 $366
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
23 $107 $391
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
23 $281 $474
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
22 $546 $786
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
20 $94 $194
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
15 $44 $56
Bladder biopsy using endoscope
A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities.
14 $81 $361
Bladder tumor removal via endoscope
This procedure involves using an endoscope to destroy or remove a large growth from the bladder.
14 $271 $1,134
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
14 $16 $60
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,653
Total received (2018-2024)
Avg $808/year across 7 years
Top 28% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
203
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,034 (89.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$619 (11.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$587
2023
$507
2022
$987
2021
$694
2020
$1,209
2019
$473
2018
$1,195

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$291
PFIZER INC.
$71
AngioDynamics, Inc.
$50
Endo Pharmaceuticals Inc.
$37
Merck Sharp & Dohme LLC
$24
Exelixis Inc.
$23
Janssen Biotech, Inc.
$20
Endo USA, Inc.
$20
Novartis Pharmaceuticals Corporation
$18
Davol Inc.
$18
ACCORD HEALTHCARE, INC.
$15
Top 3 companies account for 70.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,571
NeoTract Inc.
$691
Coloplast Corp
$648
Endo Pharmaceuticals Inc.
$472
Janssen Biotech, Inc.
$405
PFIZER INC.
$322
UROGEN PHARMA, INC.
$250
Boston Scientific Corporation
$148
BOSTON SCIENTIFIC CORPORATION
$132
180 Medical, Inc.
$83
Laborie Medical Technologies Corp.
$73
Sumitomo Pharma America, Inc.
$73
UROVANT SCIENCES INC
$65
MEDIVATION FIELD SOLUTIONS LLC
$63
Antares Pharma, Inc.
$58
Avadel Specialty Pharmaceuticals, LLC
$54
AngioDynamics, Inc.
$50
Zyla Life Sciences, Inc.
$49
Augmenix, Inc.
$39
UroGen Pharma, Inc.
$31
AMAG Pharmaceuticals, Inc.
$30
Allergan Inc.
$29
Hollister Incorporated
$27
Vertical Pharmaceuticals, LLC
$24
Merck Sharp & Dohme LLC
$24
Exelixis Inc.
$23
Covidien LP
$22
Axonics, Inc.
$20
Duchesnay USA Incorporated
$20
Endo USA, Inc.
$20
Novartis Pharmaceuticals Corporation
$18
Davol Inc.
$18
Blue Earth Diagnostics Limited
$17
PROCEPT BioRobotics Corporation
$16
TOLMAR Pharmaceuticals, Inc.
$15
ACCORD HEALTHCARE, INC.
$15
Egalet US Inc
$14
Sprout Pharmaceuticals, Inc.
$14
Dendreon Pharmaceuticals LLC
$11
Top 3 companies account for 51.5% of all-time payments
Associated products mentioned in payments ›
AMS · AQUABEAM ROBOTIC SYSTEM · ARISTA AH FlexiTip · AVEED · Addyi · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CABOMETYX · CAMCEVI · DIVIGEL · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL - ERECTILE DYSFUNCTION · GENERAL BPH · GENERAL PAIN MANAGEMENT · GENTLECATH · GentleCath · INLYTA · INTRAROSA · JELMYTO · KEYTRUDA · MYRBETRIQ · McGRATH · Myrbetriq · NANOKNIFE · NOCDURNA · Noctiva · Onli · Osphena · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · PLUVICTO · PROVENGE · REZUM · SPRIX · SpaceOAR · TITAN · Titan · UroLift · XIAFLEX · XTANDI · XYOSTED · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Wilmington?
Compare urology physicians in the Wilmington area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
19
Per 100K population
8.2
County median income
$72,892
Nearest hospital
WILMINGTON TREATMENT CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abraham is a mixed practice specialist, with above-average Medicare volume (top 0% in NC), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abraham experienced with testosterone injection?
Based on Medicare claims data, Dr. Abraham performed 171,142 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abraham receive payments from pharmaceutical companies?
Yes. Dr. Abraham received a total of $5,653 from 39 companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abraham's costs compare to other urology physicians in Wilmington?
Dr. Abraham's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abraham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →